Deep Tech Startups

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

2 investors

Alkemio develops a modular, input-agnostic separation platform for refining rare earth elements into high-purity materials. It targets the rare earths refining industry, offering an alternative to concentrated conventional refining for uses spanning electronics, semiconductors, EVs, wind turbines, defense, and robotics.

2 investors

All G produces precision-fermented proteins including bovine and human lactoferrin (such as its apo-lactoferrin LFX product), micellar caseins, and human milk proteins for use in functional foods, dietary supplements, infant formula, personal care, and therapeutics. It operates a global supply network serving customers across North America, Europe, Asia-Pacific, and China, with regulatory and clinical support for market compliance.

2 investors

Allonic is a robotics company founded by roboticists and engineers building tools to design and develop robots. It focuses on reducing the complexity, cost, and scalability barriers that keep robotic products from reaching real-world deployment.

2 investors

Allus.ai provides an AI-powered solution for industrial quality inspection, process monitoring, and anomaly detection across manufacturing sectors. The platform uses a transformer model trained on billions of data points and deploys directly on edge devices.

2 investors

alphaXiv is a platform that connects academic papers, researchers, and organizations, providing AI-grounded answers based on underlying research work. It surfaces and summarizes recent scientific papers, with a focus on AI and machine learning research.

2 investors

Also Capital is an early-stage venture capital firm that backs technically ambitious founders working on hard engineering and science problems, often at inception before markets are defined. It runs concentrated funds of roughly 15 core companies each, and has invested in over 30 companies since 2019 across deeptech, space, and other frontier sectors.

2 investors

Alsym Energy develops non-flammable, high-performance sodium-ion batteries for energy storage applications. The company serves the energy storage market with an American-made alternative to lithium-ion technology.

2 investors

Altaeros designs and manufactures autonomous tethered aerostat systems, controlled by its Aerostat Autopilot software, for commercial and government applications including telecommunications, border security, and defense surveillance. Spun out of MIT in 2010, the company deploys aerostats in the US and internationally, offering products such as the SuperTower aerial cell tower and the ST-400 multi-mission aerostat.

2 investors

Altavo develops non-invasive silent speech technology using RF sensing and artificial intelligence to help patients who have lost their voice regain natural-sounding speech. The company focuses initially on laryngectomy patients and operates as a medical device startup in Germany.

2 investors

AmberBox develops gunshot detection systems that automatically identify and report shootings to first responders in real time. The technology is designed for US public and commercial buildings to enable faster emergency response.

2 investors

Amca expands production capacity and competition for critical aerospace and defense components by addressing fragmented, single-source supply chains. The company works to enable new suppliers to manufacture components for military and commercial aviation systems.

2 investors

Amentum provides advanced engineering and technology solutions in science, security, and sustainability, serving the United States and allied governments. The company operates globally with approximately 50,000 employees across more than 70 countries.

2 investors

AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials. It offers human tissue procurement and functional assay services, including gene expression, proteomic, and metabolomic profiling, to support drug discovery and preclinical safety testing.

2 investors

AnalogAI develops neuromorphic semiconductor chips based on analog in-memory computing (AIMC), using variable-resistance synapse components to perform the vector and matrix operations needed for AI. Its technology targets on-device AI applications such as real-time AI companions, autonomous vehicles operating offline, and offline language translation.

2 investors

Andromeda offers aOS, a decentralized on-chain operating system with a suite of multi-chain tools and utilities for building Web3 applications. It uses Inter-Blockchain Communication (IBC) within the Cosmos ecosystem and provides Andromeda Digital Objects (ADOs) that let creators and developers compose Web3 apps.

2 investors

Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.

2 investors

Another Earth builds an AI-powered simulation and synthetic data engine that generates annotated variations of synthetic satellite imagery to train and scale AI models for Earth Observation. It serves geospatial and remote-sensing use cases in areas such as mining and raw materials exploration and environmental monitoring.

2 investors

AnsuR develops software for visual communication, focused on reliable image and video transmission tools. The company builds these solutions for real-world situations and serves clients through its business development and engineering teams.

2 investors

Antenna Company designs and manufactures antennas, from single elements to fully integrated systems, offering both off-the-shelf standard products and custom design and manufacturing services. It serves markets including smart energy and metering, 5G and broadband infrastructure, smart cities, agriculture and off-highway vehicles, transportation, industrial IoT, public safety, connected health, and consumer devices.

2 investors

Anvil provides a composable platform for building physical AI systems. The company serves robotics teams across research institutions, enterprises, and startups.

2 investors

AorticLab develops FLOWer, an embolic protection device featuring a 60 µm mesh designed to prevent debris-related complications during transcatheter aortic valve implantation (TAVI) and other cardiovascular procedures. The device captures debris and reduces embolic events to improve safety and patient outcomes in cardiac interventions.

2 investors

APASOMICS develops Apasomes, a drug delivery system using hydroxyapatite nanospheres designed to deliver bone-targeting medications like bisphosphonates more effectively while reducing side effects, for patients with osteoporosis and other bone diseases.

2 investors

Apeiron Investment Group is a discretionary, multi-strategy investment firm managing approximately $7 billion, making direct investments in private and listed companies as well as anchor LP investments and GP stakes in emerging asset managers. It invests across sectors with a focus on biotech, fintech and crypto, deep tech, hospitality and sports, real estate, and natural resources, with a primary focus on the US.

2 investors